4//SEC Filing
FRISSORA MARK P 4
Accession 0001193805-25-001159
CIK 0001575142other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 5:28 PM ET
Size
6.5 KB
Accession
0001193805-25-001159
Insider Transaction Report
Form 4
FRISSORA MARK P
Director
Transactions
- Other
Series D Convertible Preferred Stock
2025-08-01+1,307→ 48,501 totalFrom: 2026-02-01→ Common Stock (130,700 underlying)
Footnotes (2)
- [F1]Represents shares of Series D Convertible Preferred Stock issued as compensation for board services pursuant to that certain Board of Directors Agreement, dated February 3, 2025, between the Issuer and the Reporting Person.
- [F2]The Reporting Person's shares of Series D Convertible Preferred Stock, par value $0.0001 per share, are convertible into shares of common stock, par value $0.0001 per share, at a ratio of 100 shares of common stock for each share of Series D Convertible Preferred Stock, subject to a 10% beneficial ownership limitation. No shares of Series D Convertible Preferred Stock may be converted until six months after the date of issuance, except in the case of liquidation, whereupon the conversion will occur immediately. Each share of Series D Convertible Preferred Stock outstanding at the time of a meeting of stockholders or a solicitation of consent is entitled to 100 votes on matters of the Issuer, without regard to the beneficial ownership limitation. The right to convert does not expire.
Documents
Issuer
BIOADAPTIVES, INC.
CIK 0001575142
Entity typeother
Related Parties
1- filerCIK 0001239786
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 5:28 PM ET
- Size
- 6.5 KB